Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (621-630 of 636) with videos related to

Pageof 64
Sort By:
Hepatology (Baltimore, Md.)|November 10, 2020
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASHRohit Loomba, Mazen Noureddin, Kris V Kowdley, et al.
Lancet (London, England)|December 10, 2019
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZobair M Younossi, Vlad Ratziu, Rohit Loomba, et al.
Science Translational Medicine|December 15, 2021
Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitisXiao-Jing Zhang, Zhi-Gang She, Junyong Wang, et al.
Nature Reviews. Gastroenterology & Hepatology|October 28, 2021
Advancing the global public health agenda for NAFLD: a consensus statementJeffrey V Lazarus, Henry E Mark, Quentin M Anstee, et al.
Alimentary Pharmacology & Therapeutics|April 22, 2026
Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical OutcomesSuzanne Sharpton, Luis Antonio Díaz, Kay Pepin, et al.
Circulation Research|April 18, 2020
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19Peng Zhang, Lihua Zhu, Jingjing Cai, et al.
Cell Metabolism|June 28, 2020
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19Xiao-Jing Zhang, Juan-Juan Qin, Xu Cheng, et al.
Hepatology (Baltimore, Md.)|May 6, 2026
Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global studyVania Cari, María Ignacia Perez, Ignacio Tellez, et al.
Journal of Hepatology|November 20, 2023
Global survey of stigma among physicians and patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A Alqahtani, Khalid Alswat, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2024
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A AlQahtani, Jesús Funuyet-Salas, et al.
Pageof 64

Showing results (621-630 of 636) with videos related to

Sort By:
Pageof 64
Hepatology (Baltimore, Md.)|November 10, 2020
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASHRohit Loomba, Mazen Noureddin, Kris V Kowdley, et al.
Lancet (London, England)|December 10, 2019
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZobair M Younossi, Vlad Ratziu, Rohit Loomba, et al.
Science Translational Medicine|December 15, 2021
Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitisXiao-Jing Zhang, Zhi-Gang She, Junyong Wang, et al.
Nature Reviews. Gastroenterology & Hepatology|October 28, 2021
Advancing the global public health agenda for NAFLD: a consensus statementJeffrey V Lazarus, Henry E Mark, Quentin M Anstee, et al.
Alimentary Pharmacology & Therapeutics|April 22, 2026
Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical OutcomesSuzanne Sharpton, Luis Antonio Díaz, Kay Pepin, et al.
Circulation Research|April 18, 2020
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19Peng Zhang, Lihua Zhu, Jingjing Cai, et al.
Cell Metabolism|June 28, 2020
In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19Xiao-Jing Zhang, Juan-Juan Qin, Xu Cheng, et al.
Hepatology (Baltimore, Md.)|May 6, 2026
Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global studyVania Cari, María Ignacia Perez, Ignacio Tellez, et al.
Journal of Hepatology|November 20, 2023
Global survey of stigma among physicians and patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A Alqahtani, Khalid Alswat, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2024
The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver diseaseZobair M Younossi, Saleh A AlQahtani, Jesús Funuyet-Salas, et al.
Pageof 64